Fundamentals-based quality & risk · not a recommendation
Raw blend 59 capped to 40 by a red flag.
Raw blend 59 → capped to 40
Uniphos Enterprises Ltd scores 40/100 (Caution) on the Orion Score — weak business quality (31), strong growth (92) and strong balance-sheet safety (89). A fundamentals-based quality & risk score, not a buy/sell recommendation.
Risk checks
Forensic accounting
Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check
Technical / Momentum
Price Trend
43/100
Technical momentum companion — separate from the fundamentals-based Orion Score.
Unlock with Pro
Upgrade →Q4 FY2026
Revenue & Profit in ₹ Crores
| Quarter | Revenue | Net Profit | OPM | EPS |
|---|---|---|---|---|
| Q4 2026 | ₹26.14 | ₹-0.7 | -3.8% | ₹-0.10 |
| Q3 2026 | ₹0 | ₹-1.01 | — | ₹-0.15 |
| Q2 2026 | ₹0 | ₹23.16 | — | ₹3.33 |
| Q1 2026 | ₹5.86 | ₹-0.74 | -17.1% | ₹-0.11 |
| Q4 2025 | ₹72.9 | ₹-1.58 | -2.4% | ₹0.00 |
Revenue & Profit in ₹ Crores (Yearly)
| Year | Revenue | Net Profit | EBITDA | OPM |
|---|---|---|---|---|
| FY 2025 | ₹111.51 | ₹0.28 | ₹2.3 | -3.2% |
| FY 2024 | ₹50.65 | ₹38.61 | ₹-3.09 | -7.7% |
| FY 2023 | ₹1.47 | ₹39.23 | ₹-2.86 | -236.1% |
| FY 2022 | ₹1.22 | ₹54.6 | ₹-3.13 | -259.0% |
Top companies in the same sector by market cap
| Company | Mkt Cap | P/E | ROCE | ROE | D/E | OPM |
|---|---|---|---|---|---|---|
| UNIENTER ★ | ₹732 Cr | 35.32 | -0.17% | 0.80% | — | -3.80% |
| AETHER | ₹19,579 Cr | 89.47 | 11.68% | 9.38% | 0.19x | 21.06% |
| CHAMBLFERT | ₹18,202 Cr | 9.36 | 19.66% | 20.45% | 0.10x | 5.92% |
| ATUL | ₹18,105 Cr | 26.68 | 10.56% | 11.53% | 0.03x | 12.07% |
| ANURAS | ₹14,430 Cr | 82.63 | 8.65% | 5.76% | 0.41x | 18.15% |
| ACI | ₹6,795 Cr | 63.41 | 6.58% | 5.55% | 0.24x | 6.94% |
All values in ₹ Crores
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total Assets | ₹2,841.71 | ₹2,077.5 | ₹3,095.47 | ₹3,301.57 |
| Equity | ₹2,741.65 | ₹2,075.45 | ₹2,997.6 | ₹3,180.53 |
| Total Debt | — | — | — | — |
| Cash | ₹12.08 | ₹2.99 | ₹1.5 | ₹1.63 |
| Net Debt | — | — | — | — |
| Working Capital | ₹14.42 | ₹46 | ₹52.1 | ₹59.08 |
Q1 FY2027
Quarter-over-Quarter Trend
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Q1 FY2027 | 79.33% ↑ | 5.8% ↓ | 4.75% | 10.12% ↓ |
| Q3 FY2026 | 73.79% | 15.71% | — | 10.5% |
| Q2 FY2026 | 73.79% | 15.71% | — | 10.5% |
| Q1 FY2026 | 73.79% | 15.71% | — | 10.5% |
| Q4 FY2025 | 73.79% | 15.72% | — | 10.49% |
| Q3 FY2025 | 73.79% | 15.72% | — | 10.49% |
| Q2 FY2025 | 73.79% | 15.72% | — | 10.48% |
| Q1 FY2025 | 73.79% | 15.71% | — | 10.49% |
| Ex-Date | Action | Details |
|---|---|---|
| 2026-07-17 | DIVIDEND | Dividend - Rs 3.50 Per Share |
Ask: "Is Uniphos Enterprises Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.
Uniphos Enterprises Ltd is listed on the NSE under the Chemicals sector, Trading - Chemicals industry. ISIN: INE037A01022. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.